DOSSIER · 13F Holders · Q2 2026
BGMS 6 PERP
CYCLACEL PHARMACE 6pcnt PFDCONV
1 institutions still hold CYCLACEL PHARMACE 6pcnt PFDCONV as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 23254L207·1 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
1 institutions reported BGMS 6 PERP in Q2 2026. VSM Wealth Advisory, LLC leads at 100.0% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.